Profile | GDS4284 / 1565976_at |
Title | Chronic lymphocytic leukemia response to antisense Bcl-2 inhibitor SPC2996: peripheral blood |
Organism | Homo sapiens |
Sample | Title | Value | Rank |
---|---|---|---|
GSM687644 | Patient 401 control | 102.101 | 37 |
GSM687648 | Patient 402 control | 77.19 | 30 |
GSM687653 | Patient 403 control | 206.663 | 50 |
GSM687658 | Patient 404 control | 693.709 | 69 |
GSM687663 | Patient 411 control | 595.582 | 66 |
GSM687668 | Patient 422 control | 487.815 | 63 |
GSM687673 | Patient 424 control | 805.481 | 70 |
GSM687678 | Patient 425 control | 486.926 | 62 |
GSM687683 | Patient 427 control | 908.228 | 72 |
GSM687688 | Patient 428 control | 149.838 | 43 |
GSM687695 | Patient 441 control | 23.274 | 6 |
GSM687699 | Patient 443 control | 391.114 | 58 |
GSM687704 | Patient 444 control | 889.189 | 72 |
GSM687707 | Patient 448 control | 452.896 | 61 |
GSM687712 | Patient 449 control | 473.34 | 63 |
GSM687719 | Patient 450 control | 491.163 | 62 |
GSM687724 | Patient 451 control | 865.368 | 72 |
GSM687728 | Patient 452 control | 282.195 | 54 |
GSM687646 | Patient 401 treated 24h | 625.9 | 66 |
GSM687649 | Patient 402 treated 24h | 83.9175 | 33 |
GSM687665 | Patient 411 treated 24h | 515.102 | 63 |
GSM687651 | Patient 402 treated 4 weeks | 444.458 | 61 |
GSM687667 | Patient 411 treated 4 weeks | 646.957 | 67 |
GSM687670 | Patient 422 treated 24h | 584.611 | 65 |
GSM687671 | Patient 422 treated 4 weeks | 637.874 | 67 |
GSM687654 | Patient 403 treated 24h | 394.708 | 61 |
GSM687675 | Patient 424 treated 24h | 703.023 | 68 |
GSM687685 | Patient 427 treated 24h | 473.176 | 62 |
GSM687656 | Patient 403 treated 4 weeks | 414.19 | 61 |
GSM687677 | Patient 424 treated 4 weeks | 1145.63 | 76 |
GSM687687 | Patient 427 treated 4 weeks | 553.527 | 65 |
GSM687692 | Patient 428 treated 4h | 543.48 | 65 |
GSM687716 | Patient 449 treated 4h | 557.874 | 66 |
GSM687722 | Patient 450 treated 4h | 459.404 | 61 |
GSM687680 | Patient 425 treated 24h | 163.45 | 44 |
GSM687690 | Patient 428 treated 24h | 93.6187 | 34 |
GSM687700 | Patient 443 treated 24h | 775.292 | 69 |
GSM687705 | Patient 444 treated 24h | 709.42 | 69 |
GSM687714 | Patient 449 treated 24h | 490.989 | 64 |
GSM687721 | Patient 450 treated 24h | 396.156 | 58 |
GSM687682 | Patient 425 treated 4 weeks | 228.809 | 52 |
GSM687694 | Patient 428 treated 4 weeks | 557.94 | 65 |
GSM687702 | Patient 443 treated 4 weeks | 628.562 | 66 |
GSM687718 | Patient 449 treated 4 weeks | 494.485 | 64 |
GSM687723 | Patient 450 treated 4 weeks | 236.44 | 51 |
GSM687661 | Patient 404 treated 4h | 840.94 | 71 |
GSM687710 | Patient 448 treated 4h | 543.893 | 66 |
GSM687726 | Patient 451 treated 4h | 822.397 | 71 |
GSM687730 | Patient 452 treated 4h | 76.4901 | 18 |
GSM687660 | Patient 404 treated 24h | 322.425 | 55 |
GSM687697 | Patient 441 treated 24h | 255.051 | 48 |
GSM687709 | Patient 448 treated 24h | 364.587 | 58 |
GSM687725 | Patient 451 treated 24h | 1016.75 | 74 |
GSM687729 | Patient 452 treated 24h | 43.2368 | 16 |
GSM687727 | Patient 451 treated 4 weeks | 1265.74 | 77 |
GSM687731 | Patient 452 treated 4 weeks | 225.502 | 48 |